Cargando…
Transcriptome analyses based on genetic screens for Pax3 myogenic targets in the mouse embryo
BACKGROUND: Pax3 is a key upstream regulator of the onset of myogenesis, controlling progenitor cell survival and behaviour as well as entry into the myogenic programme. It functions in the dermomyotome of the somite from which skeletal muscle derives and in progenitor cell populations that migrate...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018477/ https://www.ncbi.nlm.nih.gov/pubmed/21143873 http://dx.doi.org/10.1186/1471-2164-11-696 |
_version_ | 1782196076798803968 |
---|---|
author | Lagha, Mounia Sato, Takahiko Regnault, Béatrice Cumano, Ana Zuniga, Aimée Licht, Jonathan Relaix, Frédéric Buckingham, Margaret |
author_facet | Lagha, Mounia Sato, Takahiko Regnault, Béatrice Cumano, Ana Zuniga, Aimée Licht, Jonathan Relaix, Frédéric Buckingham, Margaret |
author_sort | Lagha, Mounia |
collection | PubMed |
description | BACKGROUND: Pax3 is a key upstream regulator of the onset of myogenesis, controlling progenitor cell survival and behaviour as well as entry into the myogenic programme. It functions in the dermomyotome of the somite from which skeletal muscle derives and in progenitor cell populations that migrate from the somite such as those of the limbs. Few Pax3 target genes have been identified. Identifying genes that lie genetically downstream of Pax3 is therefore an important endeavour in elucidating the myogenic gene regulatory network. RESULTS: We have undertaken a screen in the mouse embryo which employs a Pax3(GFP )allele that permits isolation of Pax3 expressing cells by flow cytometry and a Pax3(PAX3-FKHR )allele that encodes PAX3-FKHR in which the DNA binding domain of Pax3 is fused to the strong transcriptional activation domain of FKHR. This constitutes a gain of function allele that rescues the Pax3 mutant phenotype. Microarray comparisons were carried out between Pax3(GFP/+ )and Pax3(GFP/PAX3-FKHR )preparations from the hypaxial dermomyotome of somites at E9.5 and forelimb buds at E10.5. A further transcriptome comparison between Pax3-GFP positive and negative cells identified sequences specific to myogenic progenitors in the forelimb buds. Potential Pax3 targets, based on changes in transcript levels on the gain of function genetic background, were validated by analysis on loss or partial loss of function Pax3 mutant backgrounds. Sequences that are up- or down-regulated in the presence of PAX3-FKHR are classified as somite only, somite and limb or limb only. The latter should not contain sequences from Pax3 positive neural crest cells which do not invade the limbs. Verification by whole mount in situ hybridisation distinguishes myogenic markers. Presentation of potential Pax3 target genes focuses on signalling pathways and on transcriptional regulation. CONCLUSIONS: Pax3 orchestrates many of the signalling pathways implicated in the activation or repression of myogenesis by regulating effectors and also, notably, inhibitors of these pathways. Important transcriptional regulators of myogenesis are candidate Pax3 targets. Myogenic determination genes, such as Myf5 are controlled positively, whereas the effect of Pax3 on genes encoding inhibitors of myogenesis provides a potential brake on differentiation. In the progenitor cell population, Pax7 and also Hdac5 which is a potential repressor of Foxc2, are subject to positive control by Pax3. |
format | Text |
id | pubmed-3018477 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30184772011-01-11 Transcriptome analyses based on genetic screens for Pax3 myogenic targets in the mouse embryo Lagha, Mounia Sato, Takahiko Regnault, Béatrice Cumano, Ana Zuniga, Aimée Licht, Jonathan Relaix, Frédéric Buckingham, Margaret BMC Genomics Research Article BACKGROUND: Pax3 is a key upstream regulator of the onset of myogenesis, controlling progenitor cell survival and behaviour as well as entry into the myogenic programme. It functions in the dermomyotome of the somite from which skeletal muscle derives and in progenitor cell populations that migrate from the somite such as those of the limbs. Few Pax3 target genes have been identified. Identifying genes that lie genetically downstream of Pax3 is therefore an important endeavour in elucidating the myogenic gene regulatory network. RESULTS: We have undertaken a screen in the mouse embryo which employs a Pax3(GFP )allele that permits isolation of Pax3 expressing cells by flow cytometry and a Pax3(PAX3-FKHR )allele that encodes PAX3-FKHR in which the DNA binding domain of Pax3 is fused to the strong transcriptional activation domain of FKHR. This constitutes a gain of function allele that rescues the Pax3 mutant phenotype. Microarray comparisons were carried out between Pax3(GFP/+ )and Pax3(GFP/PAX3-FKHR )preparations from the hypaxial dermomyotome of somites at E9.5 and forelimb buds at E10.5. A further transcriptome comparison between Pax3-GFP positive and negative cells identified sequences specific to myogenic progenitors in the forelimb buds. Potential Pax3 targets, based on changes in transcript levels on the gain of function genetic background, were validated by analysis on loss or partial loss of function Pax3 mutant backgrounds. Sequences that are up- or down-regulated in the presence of PAX3-FKHR are classified as somite only, somite and limb or limb only. The latter should not contain sequences from Pax3 positive neural crest cells which do not invade the limbs. Verification by whole mount in situ hybridisation distinguishes myogenic markers. Presentation of potential Pax3 target genes focuses on signalling pathways and on transcriptional regulation. CONCLUSIONS: Pax3 orchestrates many of the signalling pathways implicated in the activation or repression of myogenesis by regulating effectors and also, notably, inhibitors of these pathways. Important transcriptional regulators of myogenesis are candidate Pax3 targets. Myogenic determination genes, such as Myf5 are controlled positively, whereas the effect of Pax3 on genes encoding inhibitors of myogenesis provides a potential brake on differentiation. In the progenitor cell population, Pax7 and also Hdac5 which is a potential repressor of Foxc2, are subject to positive control by Pax3. BioMed Central 2010-12-08 /pmc/articles/PMC3018477/ /pubmed/21143873 http://dx.doi.org/10.1186/1471-2164-11-696 Text en Copyright ©2010 Lagha et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Lagha, Mounia Sato, Takahiko Regnault, Béatrice Cumano, Ana Zuniga, Aimée Licht, Jonathan Relaix, Frédéric Buckingham, Margaret Transcriptome analyses based on genetic screens for Pax3 myogenic targets in the mouse embryo |
title | Transcriptome analyses based on genetic screens for Pax3 myogenic targets in the mouse embryo |
title_full | Transcriptome analyses based on genetic screens for Pax3 myogenic targets in the mouse embryo |
title_fullStr | Transcriptome analyses based on genetic screens for Pax3 myogenic targets in the mouse embryo |
title_full_unstemmed | Transcriptome analyses based on genetic screens for Pax3 myogenic targets in the mouse embryo |
title_short | Transcriptome analyses based on genetic screens for Pax3 myogenic targets in the mouse embryo |
title_sort | transcriptome analyses based on genetic screens for pax3 myogenic targets in the mouse embryo |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018477/ https://www.ncbi.nlm.nih.gov/pubmed/21143873 http://dx.doi.org/10.1186/1471-2164-11-696 |
work_keys_str_mv | AT laghamounia transcriptomeanalysesbasedongeneticscreensforpax3myogenictargetsinthemouseembryo AT satotakahiko transcriptomeanalysesbasedongeneticscreensforpax3myogenictargetsinthemouseembryo AT regnaultbeatrice transcriptomeanalysesbasedongeneticscreensforpax3myogenictargetsinthemouseembryo AT cumanoana transcriptomeanalysesbasedongeneticscreensforpax3myogenictargetsinthemouseembryo AT zunigaaimee transcriptomeanalysesbasedongeneticscreensforpax3myogenictargetsinthemouseembryo AT lichtjonathan transcriptomeanalysesbasedongeneticscreensforpax3myogenictargetsinthemouseembryo AT relaixfrederic transcriptomeanalysesbasedongeneticscreensforpax3myogenictargetsinthemouseembryo AT buckinghammargaret transcriptomeanalysesbasedongeneticscreensforpax3myogenictargetsinthemouseembryo |